Fiscal Year Earnings Estimate on Cerulean Pharma Inc.(CERU)

Cerulean Pharma Inc.(CERU): For the most recent quarter end, Cerulean Pharma Inc. reported Annual Earnings of $-0.36. Based on the filings, last years Annual Earnings was, $-1.56. For the most recent quarter end, CERU reported a surprise Earnings per Share of 16.28% . The consensus estimate for current quarter is $-0.3 and for the current fiscal year, the estimate is $-1.6. For the Next fiscal year, the estimate is $-1.42 based on the consensus.

Cerulean Pharma Inc. has received $-0.3 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 1 Financial Advisor in the Stock Trading Firms. The EPS growth rate is projected at 23.08%. Cerulean Pharma Inc. reported better than expected with a surprise EPS of 16.28% or $0.07 during its most recent quarterly earnings. The Actual EPS was $-0.36 compared to the Estimated EPS of $-0.43.

Company has reported several Insider transactions to the SEC, on Feb 23, 2016, David R Walt (director) purchased 2,291 shares at 2.08 per share price.On Apr 9, 2015, Llc Cvf, (10% owner) purchased 333,333 shares at 6.00 per share price.

Cerulean Pharma Inc. (NASDAQ:CERU) witnessed a decline in the market cap on Wednesday as its shares dropped 5.93% or 0.08 points. After the session commenced at $1.33, the stock reached the higher end at $1.355 while it hit a low of $1.24. With the volume soaring to 1,035,633 shares, the last trade was called at $1.27. The company has a 52-week high of $4.33. The company has a market cap of $35 million and there are 27,435,680 shares in outstanding. The 52-week low of the share price is $0.6303.

Cerulean Pharma Inc. is a clinical-stage oncology-focused company. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma Inc. is based in Cambridge, Massachusetts.

Cerulean

Add Comment